Updates | Haclab

Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer

Addressing Bias in Artificial Intelligence in Health Care

New Mexico Cancer Center and the COME HOME Model: Pathways improving the value of community-based cancer care

Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy

High content screen for identifying small-molecule LC3B-localization modulators in a renal cancer cell line

Why we need to redefine the “cure” for cancer

Can a Machine Predict Your Death?

Most people want to die at home, but many land in hospitals getting unwanted care

Scalable principles of community-based high-value care for seriously ill individuals: Diamonds in the rough

Getting Real about Health Care Costs — A Broader Approach to Cost Stewardship in Medical Education

Beyond Genes and Molecules — A Precision Delivery Initiative for Precision Medicine

The Affordable Care Act and End-of-Life Care for Patients With Cancer

When Patients and Doctors Disagree About End-of-Life Care.

Making Predictive Analytics a Routine Part of Patient Care

Integrating Predictive Analytics Into High-Value Care: The Dawn of Precision Delivery

Cost Analysis of a Randomized Trial of Early Palliative Care in Patients with Metastatic Nonsmall-Cell Lung Cancer

Blood-Based Screening for Colon Cancer:A Disruptive Innovation or Simply a Disruption?

Advancing a Quality-of-Life Agenda in Cancer Advocacy: Beyond the War Metaphor

The Older Americans Act at 50 — Community-Based Care in a Value-Driven Era

Cancer Patients are Eager to use Immunotherapy but Sometimes Chemotherapy is the Far Better Option.